Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Heqi Bu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112021679. Sources: OpenAlex.

Their work

Papers
13 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2012: 2 papers · 2013: 3 papers · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 13

  1. Rg3 inhibits hypoxia-induced tumor exosomes from boosting pancreatic cancer vasculogenic mimicry through the HIF-1α/LARS1/mTOR axis. Co-author DOI 10.1016/j.phymed.2025.156437↗
  2. Ginsenoside Rg3 suppresses vasculogenic mimicry by impairing DVL3-maintained stemness via PAAD cell-derived exosomal miR-204 in pancreatic adenocarcinoma. Last author DOI 10.1016/j.phymed.2024.155402↗
  3. Andrographolide induces protective autophagy and targeting DJ-1 triggers reactive oxygen species-induced cell death in pancreatic cancer. Co-author DOI 10.7717/peerj.17619↗
  4. Oridonin enhances the anti-tumor activity of gemcitabine towards pancreatic cancer by stimulating Bax- and Smac-dependent apoptosis. First author DOI 10.21037/tcr-19-3000↗
  5. Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK. Co-author DOI 10.3892/or.2016.4554↗
  6. Effects of emodin on the demethylation of tumor-suppressor genes in pancreatic cancer PANC-1 cells. Co-author DOI 10.3892/or.2015.3914↗
  7. Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway. First author DOI 10.3892/mmr.2014.2584↗
  8. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. Co-author DOI 10.3892/or.2013.2888↗
  9. Involvement of endoplasmic reticulum stress in capsaicin-induced apoptosis of human pancreatic cancer cells. Co-author DOI 10.1155/2013/629750↗
  10. Involvement of the phosphoinositide 3-kinase/Akt pathway in apoptosis induced by capsaicin in the human pancreatic cancer cell line PANC-1. Co-author DOI 10.3892/ol.2012.991↗
  11. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway. Co-author DOI 10.3892/or.2013.2529↗
  12. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro. First author DOI 10.3892/ijo.2011.1285↗
  13. Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway. Co-author DOI 10.3892/ijo.2012.1519↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhaohong Wang · 7 shared papers, 2012–2025 · strength 1.00
  2. Xufan Cai · 3 shared papers, 2024–2025 · strength 0.86
  3. Shengzhang Lin · 3 shared papers, 2013–2025 · strength 0.62
  4. Sheng‐Zhang Lin · 4 shared papers, 2012–2024 · strength 0.38
  5. Tingting Zhao · 1 shared paper, 2025 · strength 0.30
  6. Dian-Lei Liu · 4 shared papers, 2012–2020 · strength 0.27
  7. Bo-Ning Cheng · 1 shared paper, 2020 · strength 0.15
  8. Shengzhang Lin · 3 shared papers, 2013–2016 · strength 0.14
  9. Jian-Hong Zhang · 3 shared papers, 2012–2013 · strength 0.10
  10. Feng-Ping Pan · 2 shared papers, 2015–2016 · strength 0.10
  11. Hao Zhang · 2 shared papers, 2015–2016 · strength 0.10
  12. Liang Chen · 2 shared papers, 2015–2016 · strength 0.10
  13. Hongfei Tong · 3 shared papers, 2012–2013 · strength 0.10
  14. Hai Huang · 2 shared papers, 2014 · strength 0.10
  15. Hongchun Guo · 2 shared papers, 2012 · strength 0.06
  16. Hongkun Zhou · 1 shared paper, 2016 · strength 0.05
  17. Junhui Cui · 1 shared paper, 2014 · strength 0.05
  18. Weitian Wei · 1 shared paper, 2014 · strength 0.05
  19. Hui Chen · 1 shared paper, 2013 · strength 0.03
  20. Jianhong Zhang · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.